France Bans Oral Nicotine Products in Forms of Pouches, Pastes, Tablets, and Liquids Starting March 2026

Sep.08.2025
France Bans Oral Nicotine Products in Forms of Pouches, Pastes, Tablets, and Liquids Starting March 2026
France's Decree No. 2025-898 bans all oral nicotine products nationwide six months after publication. Medicines and medical devices are exempt. This includes nicotine pouches, gum, lozenges, and other forms, regardless of origin. The decree is based on the Public Health Code and applies to mainland France and Wallis and Futuna Islands.

Key Points:

 

·Ban Scope: The production, manufacture, transport, import, export, possession, offer/sale, purchase, and use of these products are prohibited within France.

·Formats include: nicotine pouches (including porous pouches), pastes, beads, liquids, chewing gum, lozenges, films/strips, etc. (regardless of whether the nicotine is natural or synthetic).

·Exemptions:
1. Chewing tobacco;
2. Legally approved pharmaceuticals, medical devices, and their medicinal raw materials;
3. Food (naturally containing trace amounts of nicotine or meeting EU pesticide residue limits).

·Research Exceptions: Case-by-case exemptions for research purposes may be issued by the Minister of Health, subject to separate conditions and procedures.

·Effective Date: Le Monde and Radio France Internationale reported that the ban will officially take effect in March 2026.

 


 

2Firsts, September 8, 2025 - According to the French government's official website on September 5, the French government published Decree No. 2025-898 in the Official Gazette, which will take effect six months from its publication. This ban applies nationwide to the production, sale, possession, purchase, and use of "nicotine-containing products for oral use," with the exception of medicines and medical devices.

 

The decree specifies that the ban covers all stages of the process: production, manufacturing, transportation, import/export, possession, provision/transfer, purchase, and actual use.

 

Formats subject to the ban include:

 

Nicotine pouches (including porous pouches), pastes, beads, liquids, chewing gum, lozenges, films/strips, and more (regardless of whether the nicotine is natural or synthetic).

 

Exemptions include:

 

·Chewing tobacco;

·Legally approved medicines, medical devices, and their medicinal raw materials;

·Food (naturally containing nicotine or meeting EU pesticide residue limits).

 

The decree provides for scientific research exceptions, which can be granted for specific research projects upon the signature of the Minister of Health and in compliance with specified conditions.

 

The background document states that nicotine is classified as a "toxic substance" under the French Public Health Code, allowing for a ban on "any related operation" by decree of the Council of State. The decree has also been submitted to the European Union for technical regulatory information (notification number 2025/0110/FR) as required.

 

The decree indicates that, in addition to mainland France, the relevant provisions also apply to the Wallis and Futuna Islands.

 

Le Monde and Radio France Internationale reported that the ban will officially take effect in March 2026.

 

Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11
U.S. Military Smoking Debate Spotlights E-Cigarettes and Nicotine Pouches as a “Bridge”
U.S. Military Smoking Debate Spotlights E-Cigarettes and Nicotine Pouches as a “Bridge”
At a policy forum hosted by The Hill and sponsored by PMI US, U.S. defense health officials, lawmakers and industry representatives discussed tobacco use in the military and explored the potential role of smoke-free nicotine products — including e-cigarettes and nicotine pouches — as transitional tools to help service members reduce reliance on combustible cigarettes.
PMI
Mar.23
West Virginia House Passes 5% Income Tax Cut and Rejects Vape Tax Increase
West Virginia House Passes 5% Income Tax Cut and Rejects Vape Tax Increase
The West Virginia House of Delegates debates income tax cut bill before session's end, rejecting Senate's e-cigarette tax amendment.With one day left in the legislative session, the West Virginia House spent more than an hour debating amendments to an income tax reduction bill.
Mar.16 by 2FIRSTS.ai
UK OPSS launches vape safety campaign focusing on use, charging and disposal
UK OPSS launches vape safety campaign focusing on use, charging and disposal
The UK Office for Product Safety and Standards (OPSS) published information on March 4, 2026, launching a new campaign to raise awareness among young people about safety issues linked to using, charging and disposing of vapes.
Mar.06 by 2FIRSTS.ai
Study: Links between internalizing mental health symptoms and nicotine/tobacco use vary by gender identity among U.S. adolescents
Study: Links between internalizing mental health symptoms and nicotine/tobacco use vary by gender identity among U.S. adolescents
A study using 2020–2023 U.S. data from the ITC Youth Tobacco and Vaping Survey (ages 16–19) reports that both nicotine/tobacco use and internalizing mental health (IMH) symptoms vary across disaggregated gender identities, and that gender identity moderates the relationship between IMH symptoms and product use.
Feb.27 by 2FIRSTS.ai
Ispire Q2 FY2026 revenue falls to $20.3M as it trims lower-quality customers; A/R down nearly 20%
Ispire Q2 FY2026 revenue falls to $20.3M as it trims lower-quality customers; A/R down nearly 20%
Ispire reported a sharp year-on-year revenue decline in Q2 FY2026 as it shifted away from lower-quality customers, while cutting operating expenses and narrowing its net loss. The company also highlighted improved collections, with net accounts receivable down nearly one-fifth since June 30, 2025, alongside ongoing manufacturing and technology initiatives.
Feb.09 by 2FIRSTS.ai